Flumatinib Shows Promise in Chronic-Phase Chronic Myeloid Leukemia

Flumatinib may be more effective than Gleevec imatinib for initial treatment of chronic phase-chronic myeloid leukemia CML-CP according to study results presented at the 2019 American Society of Clinical Oncology ASCO Annual Meeting in Chicago Chronic mye [...]